All supplements

Supplement evidence

001 / 575Vitamin

Vitamin D

View my plan

The short answer

Correcting deficiency and supporting bone health when intake or status is inadequate.

Evidence and scope
Conditional or population-specific

This status does not grade the ingredient for every goal, outcome, or person.

Important limitation
Routine supplementation in vitamin-D-replete adults has not consistently prevented fractures, falls, cancer, or longer-life outcomes.
Before deciding
Excess can cause hypercalcemia and kidney injury; avoid megadoses without clinical monitoring.

01 / PRACTICAL GUIDE

Dose, absorption, and combinations

These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.

Reference range by objective
Meeting usual needs600–800 IU/day

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source
Confirmed deficiencyClinician-directed; often higher and time-limited

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source

More is not automatically better. A clinician or product label may specify a different amount.

Absorption / solubilityFat-soluble / lipid-based

Fat-soluble or lipid-based. Absorption generally improves with a meal containing fat.

How it is commonly taken

Take with a meal containing fat.

Do not combine casually

Avoid combining high-dose vitamin D with calcium without monitoring; thiazide diuretics and kidney disease require review.

Dose and use source

Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

5research papers in this ledger
2unique primary studies represented
47,186unique participants represented

These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.

Open the research timelineResearch timeline

Entries are ordered by publication year. A study period appears only when the source reports it.

2023
Mixed or qualifiedPMID 37011645 · ACTRN12613000743763

The effect of monthly vitamin D supplementation on fractures

No statistically clear overall fracture reduction was demonstrated; the authors called for more research on a possible time-dependent effect.

Study design and methods
Design
Tertiary outcome analysis of the D-Health randomized trial
Population
Australian adults aged 60–84
Intervention
Vitamin D₃ 60,000 IU/month versus placebo
Outcome
Total and site-specific fractures

Study period: 2014–2020

Open research record
2023
Mixed or qualifiedPMID 37380191 · ACTRN12613000743763

Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial

The point estimate favored vitamin D, but the confidence interval included no effect; subgroup findings require confirmation.

Study design and methods
Design
Secondary outcome analysis of the D-Health randomized trial
Population
Australian adults aged 60–84
Intervention
Vitamin D₃ 60,000 IU/month versus placebo
Outcome
Major cardiovascular events

Study period: 2014–2020

Open research record
2022
Does not support the tested claimPMID 35939577 · NCT01169259

Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults

Supplementation did not significantly reduce total, nonvertebral, or hip fractures.

Study design and methods
Design
Prespecified ancillary analysis of the VITAL randomized trial
Population
Midlife and older U.S. adults not selected for vitamin D deficiency
Intervention
Vitamin D₃ 2,000 IU/day versus placebo
Outcome
Incident fractures
Open research record
2022
Does not support the tested claimPMID 35026158 · ACTRN12613000743763

The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality

Monthly vitamin D did not reduce all-cause mortality.

Study design and methods
Design
Randomized, double-blind, placebo-controlled trial
Population
Australian adults aged 60–84, not screened for deficiency
Intervention
Vitamin D₃ 60,000 IU/month versus placebo
Outcome
All-cause mortality

Study period: 2014–2020

Open research record
2019
Does not support the tested claimPMID 30415629 · NCT01169259

Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease

Vitamin D did not lower either primary endpoint in this largely unscreened population.

Study design and methods
Design
Randomized, placebo-controlled trial
Population
Generally healthy U.S. adults: men 50+ and women 55+
Intervention
Vitamin D₃ 2,000 IU/day versus placebo
Outcome
Invasive cancer and major cardiovascular events
Open research record
Unscreened discovery appendix—not evidence8,754 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.
  1. Effects of vitamin D(3) supplementation on cardiac, muscle, and immune responses after a marathon race: a single-blind, placebo-controlled trial.Weng PW, Nanda JD, Chien YH et al. · 2026 · Journal of the International Society of Sports Nutrition · PMID 41966073Open on PubMed
  2. Risk prediction models for malnutrition in dialysis patients in China: a systematic review and meta-analysis.Liu M, Wu Y, Ye F et al. · 2026 · Renal failure · PMID 42315969Open on PubMed
  3. Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.Sanchez Cruz C, Magallanes Bajana A, de Araujo WM et al. · 2026 · Annals of medicine · PMID 41860092Open on PubMed
  4. Impact of nutritional factors on the pharmacokinetics of antipsychotics - a systematic review.Schepp M, Engel M, Hirschbeck A et al. · 2026 · Psychiatry research · PMID 42531688Open on PubMed
  5. Therapeutic potential and pathophysiological role of vitamin D in cerebral cavernous malformations: Systematic review of preclinical and clinical evidence.Alomari O, Eyvazova H, Yılmaz BN et al. · 2026 · Clinical neurology and neurosurgery · PMID 42335863Open on PubMed
  6. Vitamin D Deficiency During Pregnancy Is Associated With Greater LDL-C Increase, Elevated β-Hydroxybutyrate and Altered Neonatal Metabolic Markers-A Secondary, Pooled Analysis of the Randomized, Controlled Vitamin D and Lifestyle for Gestational Diabetes Prevention Trial (DALI).Harreiter J, Gisinger T, Mendoza LC et al. · 2026 · Endocrinology, diabetes & metabolism · PMID 42594354Open on PubMed
  7. GLP-1 receptor agonists in multiple sclerosis: a systematic review of preclinical and clinical evidence.Sajjad M, Sajjad A, Amer R et al. · 2026 · Multiple sclerosis and related disorders · PMID 42470876Open on PubMed
  8. The Serum 25-Hydroxyvitamin D Response to Supplemental Vitamin D Is Temporarily Blunted with Elevated Circulating Cytokines at Baseline.Barker T, Rogers VE, Henriksen VT · 2026 · Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · PMID 42367170Open on PubMed
  9. Prevalence and outcomes of co-occurring psychiatric and endocrine, metabolic, and nutritional disorders: An atlas based on umbrella review of 254,154,533 records.Fornaro M, Di Lorenzo C, Steardo L Jr et al. · 2026 · European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · PMID 42217371Open on PubMed
  10. Vitamin D Supplementation for Preventing Recurrent Benign Paroxysmal Positional Vertigo: A Randomized Clinical Study.Tawfeeq HA, Zaidan MA, Ghanim AK · 2026 · The Annals of otology, rhinology, and laryngology · PMID 42098930Open on PubMed
  11. Combined effect of pulmonary rehabilitation and vitamin D supplementation on pulmonary function tests in asthma patients.Fatima A, Saxena R, Singh DK et al. · 2026 · The Journal of asthma : official journal of the Association for the Care of Asthma · PMID 41860253Open on PubMed
  12. Safety and Efficacy of Weishen Decoction in Elderly Patients with Osteoporosis and Kidney-Yang Deficiency: A Randomized Trial.Gao S, Zhao B · 2026 · Journal of visualized experiments : JoVE · PMID 42615470Open on PubMed

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.

Educational information only—not medical advice. Product quality, dose, medicines, pregnancy, and kidney or liver disease can materially change safety.